Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells
It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6...
Saved in:
Published in | Biochemistry (Moscow) Vol. 73; no. 12; pp. 1300 - 1316 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Dordrecht : SP MAIK Nauka/Interperiodica
01.12.2008
SP MAIK Nauka/Interperiodica Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53⁻/⁻ mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53⁻/⁻ xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53⁻/⁻ and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53⁻/⁻ tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. |
---|---|
AbstractList | It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53⁻/⁻ mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53⁻/⁻ xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53⁻/⁻ and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53⁻/⁻ tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53(-/-) mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53(-/-) xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53(-/-) and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53(-/-) tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53 super(-/-) mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53 super(-/-) xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53 super(-/-) and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53 super(-/-) tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6′-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53 -/- mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53 -/- xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53 -/- and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro . Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53 -/- tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53-/- mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53-/- xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53-/- and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53-/- tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models. [PUBLICATION ABSTRACT] |
Author | Ivanova, O. Yu Lichinitser, M. R Chernyak, B. V Skulachev, M. V Titova, E. V Dugina, V. B Kalinina, N. I Shagieva, G. S Kopnin, B. P Lukashev, A. L Vasiliev, J. M Tkachuk, V. A Popova, E. N Fetisova, E. K Domnina, L. V Korotetskaya, M. V Efimenko, A. Yu Agapova, L. S Skulachev, V. P Stepanova, E. V Pletjushkina, O. Yu Khromova, N. V Kopnin, P. B |
Author_xml | – sequence: 1 fullname: Agapova, L. S – sequence: 2 fullname: Chernyak, B. V – sequence: 3 fullname: Domnina, L. V – sequence: 4 fullname: Dugina, V. B – sequence: 5 fullname: Efimenko, A. Yu – sequence: 6 fullname: Fetisova, E. K – sequence: 7 fullname: Ivanova, O. Yu – sequence: 8 fullname: Kalinina, N. I – sequence: 9 fullname: Khromova, N. V – sequence: 10 fullname: Kopnin, B. P – sequence: 11 fullname: Kopnin, P. B – sequence: 12 fullname: Korotetskaya, M. V – sequence: 13 fullname: Lichinitser, M. R – sequence: 14 fullname: Lukashev, A. L – sequence: 15 fullname: Pletjushkina, O. Yu – sequence: 16 fullname: Popova, E. N – sequence: 17 fullname: Skulachev, M. V – sequence: 18 fullname: Shagieva, G. S – sequence: 19 fullname: Stepanova, E. V – sequence: 20 fullname: Titova, E. V – sequence: 21 fullname: Tkachuk, V. A – sequence: 22 fullname: Vasiliev, J. M – sequence: 23 fullname: Skulachev, V. P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19120016$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV1rFDEUhoNU7Lb6A7zR4IV3s-ZjMplcSvGjUBFZez1kMyezqTPJNsks9l_5E82wCwUFJZCQnOd93xzOBTrzwQNCLylZU8rrdxtCSMOUVKSljBBOn6AVbUhbcVKTM7RaytVSP0cXKd2VKyOKP0PnVC08bVbo1xeXg9kF30enq6zjABl6vB91yuF-dksi7iG6g87uAAnrhHMI47Jj5zPEOO8zhp9g5uyCx8HivAOsB-cHvI9hiHpaY77G137ntiUsPmCwFkxe0M2PbxQXVZ6nEEvOAcawn8BnbGOY8F7wqgfrjFueDIxjeo6eWj0meHE6L9Htxw_frz5XN18_XV-9v6lMLVmuZGNsaySXVCtmDFjBOVAipGGS9bwFwWoARg1TRGyV2lpt6l4IIWuhreL8Er09-pYe7mdIuZtcWn6gPYQ5dY1SnJT1X5BRzpkUbQHf_AHehTn60kTHOKsJayUpED1CJoaUIthuH92k40NHSbcMvftr6EXz6mQ8byfoHxWnKReAHYFUSn6A-Jj8L9fXR5HVodNDdKm73TBCOaFCqkYq_hvzd8M8 |
CitedBy_id | crossref_primary_10_1134_S0006297912090106 crossref_primary_10_1134_S0006297919060014 crossref_primary_10_1186_s13020_021_00504_4 crossref_primary_10_3390_ijms25021107 crossref_primary_10_1111_j_1742_4658_2009_07269_x crossref_primary_10_4236_aar_2013_22009 crossref_primary_10_1073_pnas_0910216107 crossref_primary_10_1016_j_canlet_2021_12_032 crossref_primary_10_1002_ddrr_107 crossref_primary_10_1134_S000629790812002X crossref_primary_10_1134_S0006297909120165 crossref_primary_10_1134_S0006297914100101 crossref_primary_10_3389_fcell_2023_1048177 crossref_primary_10_1016_j_mito_2018_04_008 crossref_primary_10_1134_S0006297914100137 crossref_primary_10_1134_S0006297914020059 crossref_primary_10_1134_S0006297912070012 crossref_primary_10_1002_ijc_30054 crossref_primary_10_1016_j_mad_2010_06_003 crossref_primary_10_1134_S0006297924020135 crossref_primary_10_1002_jcp_25349 crossref_primary_10_1016_j_mad_2010_06_002 crossref_primary_10_1667_RR13708_1 crossref_primary_10_1016_j_apcata_2017_09_022 crossref_primary_10_1134_S0006297908120043 crossref_primary_10_1177_2040622320964125 crossref_primary_10_1134_S0006297911100051 crossref_primary_10_1016_j_bbabio_2008_12_008 crossref_primary_10_1089_ars_2009_2949 crossref_primary_10_1134_S0006297912070073 crossref_primary_10_1016_j_bbadis_2013_09_007 crossref_primary_10_1016_j_bbabio_2013_07_006 crossref_primary_10_1016_j_exphem_2020_05_003 crossref_primary_10_1016_j_bbadis_2009_06_005 crossref_primary_10_1002_slct_201600148 crossref_primary_10_1134_S0006297908120055 crossref_primary_10_1080_10409238_2020_1828258 crossref_primary_10_1134_S0006297910020033 crossref_primary_10_1134_S0006297915050144 crossref_primary_10_1016_j_bbabio_2020_148210 crossref_primary_10_1080_15384101_2018_1496748 crossref_primary_10_1007_s12640_022_00501_x crossref_primary_10_1016_j_mito_2012_10_015 crossref_primary_10_1021_acs_chemrev_7b00042 crossref_primary_10_1134_S0006297914100162 crossref_primary_10_1073_pnas_1307096110 crossref_primary_10_1134_S0006297912090040 crossref_primary_10_1155_2020_8837893 crossref_primary_10_1134_S0006297908120018 crossref_primary_10_1134_S0006297914100113 crossref_primary_10_4236_aar_2012_12004 crossref_primary_10_1002_slct_201800360 crossref_primary_10_1007_s11095_011_0504_8 crossref_primary_10_1155_2016_8679469 crossref_primary_10_1016_j_mito_2010_06_004 crossref_primary_10_1021_jm4012438 crossref_primary_10_1016_j_bbadis_2010_09_008 crossref_primary_10_1134_S000629791003003X crossref_primary_10_1089_ars_2013_5185 crossref_primary_10_3390_ijms21217984 crossref_primary_10_1016_j_febslet_2013_04_043 crossref_primary_10_1080_10408391003698677 |
Cites_doi | 10.1016/j.semcancer.2003.09.015 10.1134/S0006297908120043 10.1016/j.cell.2004.08.025 10.1134/S0006297908120055 10.1101/sqb.2005.70.035 10.1134/S000629790812002X 10.1016/S0960-9822(00)00002-6 10.1074/jbc.M610934200 10.1038/sj.gt.3302146 10.1074/jbc.M300547200 10.1074/jbc.M103429200 10.1158/0008-5472.CAN-06-2466 10.1038/sj.onc.1208108 10.1083/jcb.200609074 10.1016/S1097-2765(02)00520-8 10.1134/S0006297906110058 10.1016/S0169-409X(02)00047-9 10.1038/356215a0 10.1242/jcs.01631 10.1007/s00018-003-3304-4 10.1016/j.ceb.2006.08.014 10.5483/BMBRep.2007.40.1.001 10.1152/ajpheart.01283.2006 10.1038/sj.cdd.4401910 10.1038/nrc1046 10.1242/jcs.02639 10.1017/S0033583500005795 10.1023/A:1010671908204 10.1016/j.yexcr.2006.03.004 10.1007/978-1-4020-2922-6_13 10.1074/jbc.M406749200 10.1074/jbc.M306968200 10.1134/S0006297908120018 10.1134/S0006297907120139 10.1126/science.282.5393.1497 10.2174/138161206779010549 10.1615/CritRevEukarGeneExpr.v18.i1.30 10.1038/nm1320 10.1242/jcs.63.1.77 10.1016/j.critrevonc.2005.12.003 10.2174/1567201043480036 10.1158/0008-5472.CAN-07-0783 10.1007/978-1-4020-2922-6_12 10.1016/j.gde.2005.12.007 10.1134/S0026893307020136 10.1126/science.275.5306.1649 10.1073/pnas.94.20.11037 10.1016/0014-5793(96)00989-1 10.1134/S0006297907130019 10.1016/j.mrfmmm.2005.06.015 10.1101/gad.13.12.1501 10.1002/bies.10262 10.1016/j.tcb.2007.07.009 10.1038/sj.cdd.4401663 |
ContentType | Journal Article |
Copyright | MAIK Nauka 2008 |
Copyright_xml | – notice: MAIK Nauka 2008 |
DBID | FBQ CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7TM 7U9 7X7 7XB 88A 88E 88I 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M2P M7N M7P PQEST PQQKQ PQUKI Q9U 7TO 7X8 |
DOI | 10.1134/S0006297908120031 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Oncogenes and Growth Factors Abstracts ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1608-3040 |
EndPage | 1316 |
ExternalDocumentID | 1896363071 10_1134_S0006297908120031 19120016 US201301579679 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | -56 -5G -BR -EM -Y2 -~C -~X .86 .VR 06C 06D 0R~ 0VY 1N0 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 408 409 40D 40E 5GY 5VS 67N 67Z 6J9 6NX 78A 7X7 88A 88E 88I 8AO 8C1 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AAFGU AAHNG AAIAL AAJKR AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDBF ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFO ACGFS ACGOD ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESTI AETLH AEVLU AEVTX AEXYK AFFNX AFGCZ AFKRA AFLOW AFNRJ AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBNVY BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP D1J DDRTE DL5 DNIVK DPUIP DU5 DWQXO EAD EAP EBD EBLON EBS EIOEI EJD EMB EMK EMOBN EN4 EPL ESBYG ESTFP ESX F5P FBQ FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GX1 GXS HCIFZ HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ H~9 IAO IEA IHE IHR IJ- IKXTQ INH INR ITC ITM IWAJR IXC IZIGR I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KOV KPH LAK LK8 LLZTM M0L M1P M2P M4Y M7P MA- N2Q NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM OVD P2P PF0 PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I RNI RNS ROL RPX RSV RZC RZE S16 S1Z S27 S3A S3B SAP SBL SDH SHX SISQX SJN SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SV3 SZN T13 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 XU3 YLTOR Z7U Z7V Z7W Z87 ZGI ZMTXR ZOVNA ~8M ~A9 ~KM AAPBV AACDK AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AGRTI AIGIU ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX ABQSL CITATION 7QL 7TM 7U9 7XB 8FK C1K H94 K9. M7N PQEST PQUKI Q9U 7TO 7X8 |
ID | FETCH-LOGICAL-c472t-76cf8c7371a92ccef533e1057c272d38e524ee21c2905b99bfac4d555745af933 |
IEDL.DBID | AGYKE |
ISSN | 0006-2979 |
IngestDate | Sat Oct 26 00:36:52 EDT 2024 Fri Oct 25 09:01:19 EDT 2024 Tue Nov 19 06:37:55 EST 2024 Fri Dec 06 02:42:07 EST 2024 Tue Oct 15 23:34:34 EDT 2024 Sat Dec 16 12:02:19 EST 2023 Wed Dec 27 19:17:31 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | mitochondria-targeted antioxidant tumorigenesis tumor cells |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c472t-76cf8c7371a92ccef533e1057c272d38e524ee21c2905b99bfac4d555745af933 |
Notes | http://dx.doi.org/10.1134/S0006297908120031 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19120016 |
PQID | 232402870 |
PQPubID | 54009 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_69930303 proquest_miscellaneous_21332758 proquest_journals_232402870 crossref_primary_10_1134_S0006297908120031 pubmed_primary_19120016 springer_journals_10_1134_S0006297908120031 fao_agris_US201301579679 |
PublicationCentury | 2000 |
PublicationDate | 2008-12-01 |
PublicationDateYYYYMMDD | 2008-12-01 |
PublicationDate_xml | – month: 12 year: 2008 text: 2008-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: United States – name: New York |
PublicationTitle | Biochemistry (Moscow) |
PublicationTitleAbbrev | Biochemistry Moscow |
PublicationTitleAlternate | Biochemistry (Mosc) |
PublicationYear | 2008 |
Publisher | Dordrecht : SP MAIK Nauka/Interperiodica SP MAIK Nauka/Interperiodica Springer Nature B.V |
Publisher_xml | – name: Dordrecht : SP MAIK Nauka/Interperiodica – name: SP MAIK Nauka/Interperiodica – name: Springer Nature B.V |
References | Scherz-ShouvalR.ElazarZ.Trends Cell Biol.20071742242710.1016/j.tcb.2007.07.0091:CAS:528:DC%2BD2sXhtFeiur%2FI17804237 LeeS.HelfmanD. M.J. Biol. Chem.20042791885189110.1074/jbc.M3069682001:CAS:528:DC%2BD2cXisF2lug%3D%3D14559914 ThottasseryJ. V.ZambettiG. P.ArimoriK.SchuetzE. G.SchuetzJ. D.Proc. Natl. Acad. Sci. USA199794110371104210.1073/pnas.94.20.110371:CAS:528:DyaK2sXmtlCmu7o%3D9380755 HirotaK.SemenzaG. L.Crit. Rev. Oncol. Hematol.200659152610.1016/j.critrevonc.2005.12.00316716598 LogunovD. Y.IlyinskayaG. V.CherenovaL. V.VerhovskayaL. V.ShmarovM. M.ChumakovP. M.KopninB. P.NaroditskyB. S.Gene Ther.200411798410.1038/sj.gt.33021461:CAS:528:DC%2BD3sXpvVGgsLY%3D14681700 IraniK.XiaY.ZweierJ. L.SollottS. J.DerC. J.FearonE. R.SundaresanM.FinkelT.Goldschmidt-ClermontP. J.Science19972751649165210.1126/science.275.5306.16491:CAS:528:DyaK2sXhvFSms7k%3D9054359 ParasassiT.BrunelliR.Bracci-LaudieroL.GrecoG.GustafssonA. C.KrasnowskaE. K.LundebergJ.LundebergT.PittalugaE.RomanoM. C.SerafinoA.Cell Death Differ.2005121285129610.1038/sj.cdd.44016631:CAS:528:DC%2BD2MXpvFCjurw%3D15920536 GeraldD.BerraE.FrapartY. M.ChanD. A.GiacciaA. J.MansuyD.PouyssegurJ.YanivM.Mechta-GrigoriouF.Cell200411878179410.1016/j.cell.2004.08.0251:CAS:528:DC%2BD2cXnvFehtbk%3D15369676 BunzF.DutriauxA.LengauerC.WaldmanT.ZhouS.BrownJ. P.SedivyJ. M.KinzlerK. W.VogelsteinB.Science19982821497150010.1126/science.282.5393.14971:CAS:528:DyaK1cXns1yqurc%3D9822382 KopninP. B.KravchenkoI. V.FuralyovV. A.PylevL. N.KopninB. P.Oncogene2004238834884010.1038/sj.onc.12081081:CAS:528:DC%2BD2cXpvV2rtLg%3D15480427 WallaceD. C.Cold Spring Harbor Symp. Quant. Biol.20057036337410.1101/sqb.2005.70.0351:CAS:528:DC%2BD28XoslCgsb4%3D16869773 NeroevV. V.ArchipovaM. M.BakeevaL. E.FursovaA. Zh.GrigorianE. N.GrishanovaA. Yu.IomdinaE. N.IvashchenkoZh. N.KatarginaL. A.Khoroshilova-MaslovaI. P.KilinaO. V.KolosovaN. G.KopenkinE. P.KorshunovS. S.KovalevaN. A.NovikovaYu. P.PhilippovP. P.PilipenkoD. I.RobustovaO. V.SaprunovaV. B.SeninI. I.SkulachevM. V.SotnikovaL. F.StefanovaN. A.TikhomirovaN. K.TsapenkoI. V.SchipanovaA. I.ZinovkinR. A.SkulachevV. P.Biochemistry (Moscow)2008731317132810.1134/S00062979081200431:CAS:528:DC%2BD1MXjvFygtg%3D%3D NagaiH.NoguchiT.TakedaK.IchijoH.J. Biochem. Mol. Biol.200740161:CAS:528:DC%2BD2sXhsVWlurg%3D17244475 Khromova, N. V., Kopnin, P. B., Stepanova, E. V., Agapova, L. S., and Kopnin, B. P. (2008) Cancer Lett., submitted (Ms#CAN-S-08-00360). StavrovskayaA. A.Biochemistry (Moscow)200065951061:CAS:528:DC%2BD3cXitVarsLY%3D SkulachevV. P.Biochemistry (Moscow)199964141814261:CAS:528:DC%2BD3cXosFOisA%3D%3D GlavinasH.KrajcsiP.CserepesJ.SarkadiB.Curr. Drug Deliv.20041274210.2174/15672010434800361:CAS:528:DC%2BD2cXhsVSqu7Y%3D16305368 SkulachevV. P.Quart. Rev. Biophys.19962916920210.1017/S00335835000057951:CAS:528:DyaK28XlvFarsbw%3D KopninP. B.AgapovaL. S.KopninB. P.ChumakovP. M.Cancer Res.2007674571457810.1158/0008-5472.CAN-06-2466 SoussiT.HainautP.WimanK. G.25 Years of p53 Research2005Dordrecht-Berlin-Heidelberg-New YorkSpringer25529210.1007/978-1-4020-2922-6_12 QanungoS.StarkeD. W.PaiH. V.MieyalJ. J.NieminenA. L.J. Biol. Chem.2007282184271843610.1074/jbc.M6109342001:CAS:528:DC%2BD2sXmsVOks70%3D17468103 MainprizeT. G.TaylorM. D.RutkaJ. T.DirksP. B.J. Neurooncol.20015120521810.1023/A:10106719082041:STN:280:DC%2BD3MzksVyiuw%3D%3D11407593 GilesG. I.Curr. Pharm. Des.2006124427444310.2174/1381612067790105491:CAS:528:DC%2BD28XhtlSisrrM17168752 KalininaE. V.ChernovN. N.SaprinA. N.KotovaY. N.AndreevY. A.SolomkaV. S.ScherbakN. P.Biochemistry (Moscow)2006711200120610.1134/S00062979061100581:CAS:528:DC%2BD28Xht1GmtLfL HarmsK.NozellS.ChenX.Cell Mol. Life Sci.20046182284210.1007/s00018-003-3304-41:CAS:528:DC%2BD2cXls1Grt7s%3D15095006 WuW. S.Cancer Metastasis Rev.20062569570510.1007/s10555-006-9037-81:CAS:528:DC%2BD2sXisVyrsg%3D%3D17160708 BlanchetotC.BoonstraJ.Crit. Rev. Eukaryot. Gene Expr.20081835451:CAS:528:DC%2BD2sXhsVyhurfK18197784 CarcamoJ. M.GoldeD. W.Mutat. Res.2006593647916085125 PugachevaE. N.RoegiersF.GolemisE. A.Curr. Opin. Cell Biol.20061850751510.1016/j.ceb.2006.08.0141:CAS:528:DC%2BD28XpsVOjt7c%3D16919436 VafaO.WadeM.KernS.BeecheM.PanditaT. K.HamptonG. M.WahlG. M.Mol. Cell.200291031104410.1016/S1097-2765(02)00520-81:CAS:528:DC%2BD38XksFKjtLc%3D12049739 AntonenkoY. N.AvetisyanA. V.BakeevaL. E.ChernyakB. V.ChertkovV. A.DomninaL. V.IvanovaO. Yu.IzyumovD. S.KhailovaL. S.KlishinS. S.KorshunovaG. A.LyamzaevK. G.MuntyanM. S.NepryakhinaO. K.PashkovskayaA. A.PletjushkinaO. Yu.PustovidkoA. V.RoginskyV. A.RokitskayaT. I.RuugeE. K.SaprunovaV. B.SeverinaI. I.SimonyanR. A.SkulachevI. V.SkulachevM. V.SumbatyanN. V.SviryaevaI. V.TashlitskyV. N.VassilievJ. M.VyssokikhM. Yu.YaguzhinskyL. S.ZamyatninA. A.Jr.SkulachevV. P.Biochemistry (Moscow)2008731273128710.1134/S00062979081200181:CAS:528:DC%2BD1MXjvFynsg%3D%3D KopninB. P.StromskayaT. P.KondratovR. V.OssovskayaV. S.PugachevaE. N.RybalkinaE. Y.KhokhlovaO. A.ChumakovP. M.Oncol. Res.199572993061:CAS:528:DyaK2MXpt1ymu7w%3D8527864 KopninB. P.KhromovaN. V.KopninP. B.AgapovaL. S.Clin. Oncohemat.20081311 JacksT.RemingtonL.WilliamsB. O.SchmittE. M.HalachmiS.BronsonR. T.WeinbergR. A.Curr. Biol.199441710.1016/S0960-9822(00)00002-61:CAS:528:DyaK2cXhvVygu7k%3D7922305 ShiH.CalvezF. L.OlivierM.HainautP.HainautP.WimanK. G.25 Years of p53 Research2005Dordrecht-Berlin-Heidelberg-New YorkSpringer29332010.1007/978-1-4020-2922-6_13 DonehowerL. A.HarveyM.SlagleB. L.McArthurM. J.MontgomeryC. A.Jr.ButelJ. S.BradleyA.Nature199235621522110.1038/356215a01:CAS:528:DyaK38XitFajsLc%3D1552940 ZhangJ.BetsonM.ErasmusJ.ZeikosK.BaillyM.CramerL. P.BragaV. M. M.J. Cell Sci.20051185549556210.1242/jcs.026391:CAS:528:DC%2BD28XjvFOhtQ%3D%3D16291727 DesMaraisV.GhoshM.EddyR.CondeelisJ.J. Cell Sci.2005118192610.1242/jcs.016311:CAS:528:DC%2BD2MXhsVCrtb8%3D15615780 KopninB. P.Mol. Biol. (Moscow)2007413693801:STN:280:DC%2BD2szgsVamsg%3D%3D SkulachevV. P.FEBS Lett.199639771010.1016/0014-5793(96)00989-11:CAS:528:DyaK28XmvFaqsLo%3D8941703 SkulachevV. P.NystromT.OsiewacH. D.Topics in Current Genetics, Vol. 32003Berlin-HeidelbergSpringer-Verlag191238 AnisimovV. N.BakeevaL. E.EgorminP. A.FilenkoO. F.IsakovaE. F.ManskikhV. N.MikhelsonV. M.PanteleevaA. A.PasyukovaE. G.PilipenkoD. I.PiskunovaT. S.PopovichI. G.RoshchinaN. V.RybinaO. Yu.SamoylovaT. A.SaprunovaV. B.SemenchenkoA. V.SkulachevM. V.SpivakI. M.Tsybul’koE. A.TyndykM. L.VyssokikhM. Yu.YurovaM. N.ZabezhinskyM. A.SkulachevV. P.Biochemistry (Moscow)2008731329134210.1134/S00062979081200551:CAS:528:DC%2BD1MXjvFygtA%3D%3D BellE. L.KlimovaT. A.EisenbartJ.MoraesC. T.MurphyM. P.BudingerG. R.ChandeN. S.J. Cell Biol.20071771029103610.1083/jcb.2006090741:CAS:528:DC%2BD2sXmvF2ru7o%3D17562787 BrembeckF. H.RosarioM.BirchmeierW.Curr. Opin. Genet. Dev.200616515910.1016/j.gde.2005.12.0071:CAS:528:DC%2BD28XlvVOhtg%3D%3D16377174 KabanovA. V.BatrakovaE. V.AlakhovV. Y.Adv. Drug Deliv. Rev.20025475977910.1016/S0169-409X(02)00047-91:CAS:528:DC%2BD38XmsVeqt74%3D12204601 SampathJ.SunD.KiddV. J.GrenetJ.GandhiA.ShapiroL. H.WangQ.ZambettiG. P.SchuetzJ. D.J. Biol. Chem.2001276393592936710.1074/jbc.M1034292001:CAS:528:DC%2BD3MXnvVemtrs%3D11483599 ChumakovP. M.Biochemistry (Moscow)2007721399142110.1134/S00062979071300191:CAS:528:DC%2BD1cXitFWkt7g%3D ZhangD. X.GuttermanD. D.Am. J. Physiol. Heart Circ. Physiol.2007292H2023203110.1152/ajpheart.01283.20061:CAS:528:DC%2BD2sXlslSitLg%3D17237240 SherrC. J.RobertsJ. M.Genes Dev.1999131501151210.1101/gad.13.12.15011:CAS:528:DyaK1MXktlOhsLs%3D10385618 SkulachevV. P.Biochemistry (Moscow)2007721385139610.1134/S00062979071201391:CAS:528:DC%2BD1cXpsl0%3D SablinaA. A.BudanovA. V.IlyinskayaG. V.AgapovaL. S.KravchenkoJ. E.ChumakovP. M.Nat. Med.2005111306131310.1038/nm13201:CAS:528:DC%2BD2MXht1yisrzJ16286925 LozanoE.BetsonM.BragaV. M. M.BioEssays20032545246310.1002/bies.102621:CAS:528:DC%2BD3sXktF2ksLY%3D12717816 QanungoS.WangM.NieminenA. L.J. Biol. Chem.2004279504555046410.1074/jbc.M4067492001:CAS:528:DC%2BD2cXhtVWjs7fE15375156 BakeevaL. E.BarskovI. V.EgorovM. V.IsaevN. K.KapelkoV. I.KazachenkoA. V.KirpatovskyV. I.KozlovskyS. V.LakomkinV. L.LevinaS. V.PisarenkoO. I.PlotnikovE. Y.SaprunovaV. B.SerebryakovaL. I.SkulachevM. V.StelmashookE. V.StudnevaI. M.TskitishviliO. V.VasilevaA. K.VictorovI. V.ZorovD. B.SkulachevV. P.Biochemistry (Moscow)2008731288129910.1134/S000629790812002X1:CAS:528:DC%2BD1MXjvFygtQ%3D%3D SablinaA. A.ChumakovP. M.KopninB. P.J. Biol. Chem.2003278273622737110.1074/jbc.M3005472001:CAS:528:DC%2BD3sXlsFKksL4%3D12750388 CampbellP. M.DerC. J.Semin. Cancer Biol.20041410511410.1016/j.semcancer.2003.09.0151:CAS:528:DC%2BD2cXht1KhtLk%3D15018894 HuschtschaL. I.HollidayR.J. Cell Sci.19836377991:CAS:528:DyaL3sXlslelur4%3D6313714 XiaC.MengQ.LiuL. Z.RojanasakulY.WangX. R.JiangB. H.Cancer Res.200767108231083010.1158/0008-5472.CAN-07-07831:CAS:528:DC%2BD2sXhtlSls7fF18006827 AlexandrovaA. Y.KopninP. B.VasilievJ. M.KopninB. P.Exp. Cell Res.20063122066207310.1016/j.yexcr.2006.03.0041:CAS:528:DC%2BD28Xls1GqsL4%3D16624288 HussainS. P.HofsethL. J.HarrisC. C.Nat. Rev. Cancer2003327628510.1038/nrc10461:CAS:528:DC%2BD3sXisFajtLw%3D12671666 LevineA. J.HuW.FengZ.Cell Death Differ.2006131027103610.1038/sj.cdd.44019101:CAS:528:DC%2BD28Xks1Ortbw%3D16557269 T. Soussi (1203_CR30) 2005 S. Lee (1203_CR52) 2004; 279 O. Vafa (1203_CR12) 2002; 9 P. M. Campbell (1203_CR51) 2004; 14 B. P. Kopnin (1203_CR17) 2008; 1 K. Hirota (1203_CR40) 2006; 59 T. G. Mainprize (1203_CR43) 2001; 51 J. Zhang (1203_CR48) 2005; 118 V. P. Skulachev (1203_CR1) 2007; 72 D. Y. Logunov (1203_CR39) 2004; 11 J. M. Carcamo (1203_CR18) 2006; 593 A. A. Sablina (1203_CR38) 2003; 278 L. E. Bakeeva (1203_CR25) 2008; 73 S. Qanungo (1203_CR61) 2007; 282 P. B. Kopnin (1203_CR37) 2004; 23 B. P. Kopnin (1203_CR6) 2007; 41 C. Xia (1203_CR16) 2007; 67 E. V. Kalinina (1203_CR34) 2006; 71 J. Sampath (1203_CR57) 2001; 276 V. N. Anisimov (1203_CR27) 2008; 73 J. V. Thottassery (1203_CR56) 1997; 94 H. Nagai (1203_CR8) 2007; 40 A. J. Levine (1203_CR44) 2006; 13 T. Parasassi (1203_CR50) 2005; 12 D. X. Zhang (1203_CR22) 2007; 292 B. P. Kopnin (1203_CR35) 1995; 7 V. P. Skulachev (1203_CR21) 2003 A. A. Sablina (1203_CR10) 2005; 11 V. DesMarais (1203_CR53) 2005; 118 L. A. Donehower (1203_CR28) 1992; 356 P. M. Chumakov (1203_CR32) 2007; 72 Y. N. Antonenko (1203_CR24) 2008; 73 V. P. Skulachev (1203_CR20) 1996; 29 G. I. Giles (1203_CR7) 2006; 12 P. B. Kopnin (1203_CR11) 2007; 67 D. C. Wallace (1203_CR3) 2005; 70 A. V. Kabanov (1203_CR58) 2002; 54 V. P. Skulachev (1203_CR59) 1999; 64 C. J. Sherr (1203_CR42) 1999; 13 F. H. Brembeck (1203_CR47) 2006; 16 V. V. Neroev (1203_CR26) 2008; 73 C. Blanchetot (1203_CR5) 2008; 18 R. Scherz-Shouval (1203_CR23) 2007; 17 F. Bunz (1203_CR33) 1998; 282 E. N. Pugacheva (1203_CR46) 2006; 18 V. P. Skulachev (1203_CR19) 1996; 397 A. A. Stavrovskaya (1203_CR54) 2000; 65 K. Irani (1203_CR13) 1997; 275 W. S. Wu (1203_CR4) 2006; 25 E. L. Bell (1203_CR41) 2007; 177 E. Lozano (1203_CR49) 2003; 25 D. Gerald (1203_CR14) 2004; 118 T. Jacks (1203_CR29) 1994; 4 H. Shi (1203_CR31) 2005 1203_CR15 K. Harms (1203_CR45) 2004; 61 L. I. Huschtscha (1203_CR36) 1983; 63 S. P. Hussain (1203_CR2) 2003; 3 H. Glavinas (1203_CR55) 2004; 1 S. Qanungo (1203_CR60) 2004; 279 A. Y. Alexandrova (1203_CR9) 2006; 312 |
References_xml | – volume: 14 start-page: 105 year: 2004 ident: 1203_CR51 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2003.09.015 contributor: fullname: P. M. Campbell – volume: 1 start-page: 3 year: 2008 ident: 1203_CR17 publication-title: Clin. Oncohemat. contributor: fullname: B. P. Kopnin – volume: 73 start-page: 1317 year: 2008 ident: 1203_CR26 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297908120043 contributor: fullname: V. V. Neroev – volume: 118 start-page: 781 year: 2004 ident: 1203_CR14 publication-title: Cell doi: 10.1016/j.cell.2004.08.025 contributor: fullname: D. Gerald – volume: 25 start-page: 695 year: 2006 ident: 1203_CR4 publication-title: Cancer Metastasis Rev. contributor: fullname: W. S. Wu – volume: 73 start-page: 1329 year: 2008 ident: 1203_CR27 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297908120055 contributor: fullname: V. N. Anisimov – volume: 70 start-page: 363 year: 2005 ident: 1203_CR3 publication-title: Cold Spring Harbor Symp. Quant. Biol. doi: 10.1101/sqb.2005.70.035 contributor: fullname: D. C. Wallace – volume: 73 start-page: 1288 year: 2008 ident: 1203_CR25 publication-title: Biochemistry (Moscow) doi: 10.1134/S000629790812002X contributor: fullname: L. E. Bakeeva – volume: 4 start-page: 1 year: 1994 ident: 1203_CR29 publication-title: Curr. Biol. doi: 10.1016/S0960-9822(00)00002-6 contributor: fullname: T. Jacks – volume: 64 start-page: 1418 year: 1999 ident: 1203_CR59 publication-title: Biochemistry (Moscow) contributor: fullname: V. P. Skulachev – volume: 282 start-page: 18427 year: 2007 ident: 1203_CR61 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M610934200 contributor: fullname: S. Qanungo – volume: 11 start-page: 79 year: 2004 ident: 1203_CR39 publication-title: Gene Ther. doi: 10.1038/sj.gt.3302146 contributor: fullname: D. Y. Logunov – volume: 278 start-page: 27362 year: 2003 ident: 1203_CR38 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M300547200 contributor: fullname: A. A. Sablina – volume: 276 start-page: 39359 year: 2001 ident: 1203_CR57 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103429200 contributor: fullname: J. Sampath – volume: 65 start-page: 95 year: 2000 ident: 1203_CR54 publication-title: Biochemistry (Moscow) contributor: fullname: A. A. Stavrovskaya – volume: 67 start-page: 4571 year: 2007 ident: 1203_CR11 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-2466 contributor: fullname: P. B. Kopnin – volume: 23 start-page: 8834 year: 2004 ident: 1203_CR37 publication-title: Oncogene doi: 10.1038/sj.onc.1208108 contributor: fullname: P. B. Kopnin – volume: 177 start-page: 1029 year: 2007 ident: 1203_CR41 publication-title: J. Cell Biol. doi: 10.1083/jcb.200609074 contributor: fullname: E. L. Bell – volume: 9 start-page: 1031 year: 2002 ident: 1203_CR12 publication-title: Mol. Cell. doi: 10.1016/S1097-2765(02)00520-8 contributor: fullname: O. Vafa – volume: 71 start-page: 1200 year: 2006 ident: 1203_CR34 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297906110058 contributor: fullname: E. V. Kalinina – volume: 54 start-page: 759 year: 2002 ident: 1203_CR58 publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(02)00047-9 contributor: fullname: A. V. Kabanov – volume: 356 start-page: 215 year: 1992 ident: 1203_CR28 publication-title: Nature doi: 10.1038/356215a0 contributor: fullname: L. A. Donehower – volume: 118 start-page: 19 year: 2005 ident: 1203_CR53 publication-title: J. Cell Sci. doi: 10.1242/jcs.01631 contributor: fullname: V. DesMarais – volume: 61 start-page: 822 year: 2004 ident: 1203_CR45 publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-003-3304-4 contributor: fullname: K. Harms – volume: 18 start-page: 507 year: 2006 ident: 1203_CR46 publication-title: Curr. Opin. Cell Biol. doi: 10.1016/j.ceb.2006.08.014 contributor: fullname: E. N. Pugacheva – volume: 40 start-page: 1 year: 2007 ident: 1203_CR8 publication-title: J. Biochem. Mol. Biol. doi: 10.5483/BMBRep.2007.40.1.001 contributor: fullname: H. Nagai – volume: 292 start-page: H2023 year: 2007 ident: 1203_CR22 publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.01283.2006 contributor: fullname: D. X. Zhang – volume: 13 start-page: 1027 year: 2006 ident: 1203_CR44 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401910 contributor: fullname: A. J. Levine – volume: 3 start-page: 276 year: 2003 ident: 1203_CR2 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1046 contributor: fullname: S. P. Hussain – volume: 118 start-page: 5549 year: 2005 ident: 1203_CR48 publication-title: J. Cell Sci. doi: 10.1242/jcs.02639 contributor: fullname: J. Zhang – volume: 29 start-page: 169 year: 1996 ident: 1203_CR20 publication-title: Quart. Rev. Biophys. doi: 10.1017/S0033583500005795 contributor: fullname: V. P. Skulachev – volume: 51 start-page: 205 year: 2001 ident: 1203_CR43 publication-title: J. Neurooncol. doi: 10.1023/A:1010671908204 contributor: fullname: T. G. Mainprize – volume: 312 start-page: 2066 year: 2006 ident: 1203_CR9 publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2006.03.004 contributor: fullname: A. Y. Alexandrova – start-page: 293 volume-title: 25 Years of p53 Research year: 2005 ident: 1203_CR31 doi: 10.1007/978-1-4020-2922-6_13 contributor: fullname: H. Shi – volume: 279 start-page: 50455 year: 2004 ident: 1203_CR60 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M406749200 contributor: fullname: S. Qanungo – volume: 279 start-page: 1885 year: 2004 ident: 1203_CR52 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M306968200 contributor: fullname: S. Lee – volume: 73 start-page: 1273 year: 2008 ident: 1203_CR24 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297908120018 contributor: fullname: Y. N. Antonenko – ident: 1203_CR15 – volume: 72 start-page: 1385 year: 2007 ident: 1203_CR1 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297907120139 contributor: fullname: V. P. Skulachev – volume: 282 start-page: 1497 year: 1998 ident: 1203_CR33 publication-title: Science doi: 10.1126/science.282.5393.1497 contributor: fullname: F. Bunz – volume: 12 start-page: 4427 year: 2006 ident: 1203_CR7 publication-title: Curr. Pharm. Des. doi: 10.2174/138161206779010549 contributor: fullname: G. I. Giles – volume: 18 start-page: 35 year: 2008 ident: 1203_CR5 publication-title: Crit. Rev. Eukaryot. Gene Expr. doi: 10.1615/CritRevEukarGeneExpr.v18.i1.30 contributor: fullname: C. Blanchetot – volume: 11 start-page: 1306 year: 2005 ident: 1203_CR10 publication-title: Nat. Med. doi: 10.1038/nm1320 contributor: fullname: A. A. Sablina – volume: 7 start-page: 299 year: 1995 ident: 1203_CR35 publication-title: Oncol. Res. contributor: fullname: B. P. Kopnin – volume: 63 start-page: 77 year: 1983 ident: 1203_CR36 publication-title: J. Cell Sci. doi: 10.1242/jcs.63.1.77 contributor: fullname: L. I. Huschtscha – start-page: 191 volume-title: Topics in Current Genetics, Vol. 3 year: 2003 ident: 1203_CR21 contributor: fullname: V. P. Skulachev – volume: 59 start-page: 15 year: 2006 ident: 1203_CR40 publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2005.12.003 contributor: fullname: K. Hirota – volume: 1 start-page: 27 year: 2004 ident: 1203_CR55 publication-title: Curr. Drug Deliv. doi: 10.2174/1567201043480036 contributor: fullname: H. Glavinas – volume: 67 start-page: 10823 year: 2007 ident: 1203_CR16 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-0783 contributor: fullname: C. Xia – start-page: 255 volume-title: 25 Years of p53 Research year: 2005 ident: 1203_CR30 doi: 10.1007/978-1-4020-2922-6_12 contributor: fullname: T. Soussi – volume: 16 start-page: 51 year: 2006 ident: 1203_CR47 publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/j.gde.2005.12.007 contributor: fullname: F. H. Brembeck – volume: 41 start-page: 369 year: 2007 ident: 1203_CR6 publication-title: Mol. Biol. (Moscow) doi: 10.1134/S0026893307020136 contributor: fullname: B. P. Kopnin – volume: 275 start-page: 1649 year: 1997 ident: 1203_CR13 publication-title: Science doi: 10.1126/science.275.5306.1649 contributor: fullname: K. Irani – volume: 94 start-page: 11037 year: 1997 ident: 1203_CR56 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.94.20.11037 contributor: fullname: J. V. Thottassery – volume: 397 start-page: 7 year: 1996 ident: 1203_CR19 publication-title: FEBS Lett. doi: 10.1016/0014-5793(96)00989-1 contributor: fullname: V. P. Skulachev – volume: 72 start-page: 1399 year: 2007 ident: 1203_CR32 publication-title: Biochemistry (Moscow) doi: 10.1134/S0006297907130019 contributor: fullname: P. M. Chumakov – volume: 593 start-page: 64 year: 2006 ident: 1203_CR18 publication-title: Mutat. Res. doi: 10.1016/j.mrfmmm.2005.06.015 contributor: fullname: J. M. Carcamo – volume: 13 start-page: 1501 year: 1999 ident: 1203_CR42 publication-title: Genes Dev. doi: 10.1101/gad.13.12.1501 contributor: fullname: C. J. Sherr – volume: 25 start-page: 452 year: 2003 ident: 1203_CR49 publication-title: BioEssays doi: 10.1002/bies.10262 contributor: fullname: E. Lozano – volume: 17 start-page: 422 year: 2007 ident: 1203_CR23 publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2007.07.009 contributor: fullname: R. Scherz-Shouval – volume: 12 start-page: 1285 year: 2005 ident: 1203_CR50 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401663 contributor: fullname: T. Parasassi |
SSID | ssj0002093 |
Score | 2.2165146 |
Snippet | It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be... |
SourceID | proquest crossref pubmed springer fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1300 |
SubjectTerms | Aging Animal models Animals Antioxidants ATP-Binding Cassette, Sub-Family B, Member 1 - genetics ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry Cell Differentiation - drug effects Cell Line, Tumor Cell Proliferation - drug effects Cell Transformation, Neoplastic - drug effects Cells, Cultured Female Humans Life Sciences Male Mice Mice, Inbred C57BL Mice, Knockout Mice, Nude Microbiology Mitochondria Mitochondria - chemistry Mitochondria - drug effects Mitochondria - metabolism Neoplasm Transplantation Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - physiopathology Neovascularization, Pathologic - drug therapy Oncology Plastoquinone - analogs & derivatives Plastoquinone - metabolism Plastoquinone - pharmacology Reactive Oxygen Species - metabolism Transplantation, Heterologous Tumor Suppressor Protein p53 - antagonists & inhibitors Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism Tumors |
SummonAdditionalLinks | – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEF5sRfRFtFUb62UexAclNdlLcvZJ6sFShQpSD_QtJHvRgzaJJzmi_8qf6Mwm6UFqfQkh2SW7zOxcMt_MMPZMOYlWhkxizb1AB8XlcaW9j12VZVp5JHnISjv5kB0v5PszdTZic7oRVjnJxCCobWPoH_kr0vwJReVet99jahpFwdWxg8YWu56SnqNE8fkG4cGTseYuOs1c53oMaqZCUoJwktEz1IgEz0r_Uktbvmz-ZXFeipYGJXR0h90erUc4HMh9l11z9Q7bPazRcz7_Bc8h4DnDj_IdduPNdHdzPnV122W_T_AIo8irLXJePODAnYUWjege17Gsm9qBRbb8ESqCd1B20DfNN7oC1ZZYrdZtD-6nM4FlofGANiSEZkcwor0OQBzAu_rLslpSDB8G0AgNPf36MQWc1a_PmxXYDWIJKM8FWiVi66ioBT2ioEJ3jy2O3n6aH8dj14bYyJz3cZ4ZPzO5yNNSc2OcR4PSUTdhw3NuxcwpLp3jqeE6UZXWlS-NtEqpXKrSayHus23a6x4Dbg3OUDYrvZU-q2bW4zTKNrYzXvI0Yi8mohXtUJyjCE6NkMUlCkdsD8lalJ9ReBaLU04h25QycXMdsf2J1sV4hLviguEi9vTiLRKL9l7WrlnjEHTwOTpcV4_I0PxDMSoi9mBgoc06NS0rzSL2cuKpzbev3MTD_650n90KcJaAtnnEtvvV2j1Gm6mvnoST8Qd0_RDc priority: 102 providerName: ProQuest |
Title | Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells |
URI | https://link.springer.com/article/10.1134/S0006297908120031 https://www.ncbi.nlm.nih.gov/pubmed/19120016 https://www.proquest.com/docview/232402870 https://search.proquest.com/docview/21332758 https://search.proquest.com/docview/69930303 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELf2IQQvfGzAwqD4AfEAStXYSVw_tqVlgDYBo1J5ihJ_sKpbUrUpAv4q_kTunKQV6vawlyRK7CQnn893vt_dEfIqMiFoGWHHl8xyMFCM8DNprW-yOJaRhSF3UWmnZ_HJOPw4iSY7hK23LvJZu_FIOkFdlR0JMaS3EzMpJKxhCKgCi2cflh6cjPu9998_Ddfyl3XqVLtgK2OH2pd57Uv-W412bVpcp2huOUnd2jN6UMUDLl3KQoSczNqrMmurP9sJHW9B1kNyv1ZFaa_inUdkx-QH5LCXgxl-9Zu-pg4c6nbdD8idfnN1d9CUiDskf09BHoD8zDWwsV-Byo2mc9DIS6Bumhe5oRp4_KdLL76k6ZKWRXGJR4qJKhaL1byk5pdRjv9pYSkopNRVTqI1dKxNeZt-yC-m2RQBAbRCoGDT89mXgEKvcnVVLKjewJ8oBs3QecR9bTBDBt5CD8XyMRmPht8GJ35dAsJXoWClL2Jlu0pwEaSSKWUsaKcGSxMrJpjmXROx0BgWKCY7USZlZlMV6iiKRBilVnL-hOwhrUeEMq2gR6Tj1OrQxllXW-iGocu6y1IWeORNwwrJvMr0kTgLiYfJ1ih55AiYJUl_gCROxucM_b8BhvUK6ZHjhoOSWh4sE9RbO-hT9sjL9VMYLKQ9zU2xgiYB5wyst5tbxKBLgkzmHnlaMebmPyX-VhB75G3DZZtv30jEs1u1Pib3HFbGQXmek71ysTIvQCErsxbZFRMBx-4gaMFs7L_rj1r1rIRzf3j2-Ss8HbPeP1tuLtI |
link.rule.ids | 314,780,784,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,41081,41523,42150,42592,43310,43579,43805,52111,52234,73745,74014,74302 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELdYJzReEGzAwoDdA-IBlK1x4qR-Qtu0qYO1ArZKe4sS_4FqW1KaFMG34iNy5ySt0BgvUeTYiq07n-98v7tj7LUwEWoZUd-X3IZooJjEz6W1vsnjWAqLJHdRaaNxPJxEHy7FZYvNqVpYZScTnaDWpaI78n06-fvklXs_--5T0ShyrrYVNNbYOiVOFz22fng8_vRlKYp5v826i2Yzl4ls3ZpBGFGIcD-mNjwTCaAV_HUwrdms_JfOectf6o6hk0fsYas_wkFD8Mfsnik22dZBgbbzzS94Aw7R6a7KN9n9w-5t46ir67bFfo9wE6PQKzTynt8gwY2GGarRNc5jWpSFAY2M-cPlBK8gq6Auy2t6AmWXmM8XsxrMT6Mc00JpAbVIcOWOoMV77UG4B6fFt2k-JS8-NLAR6np-9TkAHFUvbso56BVmCSjSBWYi9LWhtBbURG6F6gmbnBxfHA39tm6Dr6KE134SKztQSZgEmeRKGYsqpaF6woonXIcDI3hkDA8Ul32RS5nbTEVaCJFEIrMyDJ-yHq11mwHXCkcIHWdWRzbOB9riMIo31gOe8cBjbzuipbMmPUfqzJowSm9R2GPbSNY0-4riM52cc3LaBhSLm0iP7XS0TttNXKVLlvPY7vIrEovWnhWmXGAXNPE5mlx394hRAURBGnrsWcNCq3lKmlYQe-xdx1Orf9-5iOf_neku2xhejM7Ss9Pxxx32wIFbHPbmBevV84V5iRpUnb9q98kffEwVag |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB7RVDwuCFqgpkD3gDiA3Nprr509obY0aoFGhRKpN8veB0RQOyQOgn_FT2Rms06ESrlYlr0r72pm5-H5ZgbguTApWhlpFEpuE3RQTB5W0trQVFkmhUWSu6y002F2PErfXogLX1Jo5mGVnUx0glo3iv6R75Hmjygqt2c9KuLszeD15HtIDaQo0Oq7aazBOirFiPdg_eBoePZxKZZ55CvwogvNZS59iDNOUkoXjjJ6hvqRwFrxX0pqzZbNv-zPK7FTp5IG9-CutyXZ_oL49-GGqTdgc79GP_ryF3vBHLrT_TbfgJsH3d3tw67H2yb8PsUDjQKw1siH4QIVbjSboEnd4jrGdVMbppFJf7j64DNWzljbNN_oyqjSxHQ6n7TM_DTKMTBrLEOLkrnWR8xjv3ZZsstO6i_jakwRfbaAkNDQ868fYoaz2vllM2V6hV9ilPXCJiIJtaESF_SIQgyzBzAaHH06PA59D4dQpTlvwzxTtq_yJI9LyZUyFs1LQ72FFc-5TvpG8NQYHisuI1FJWdlSpVoIkaeitDJJHkKP9roFjGuFM4TOSqtTm1V9bXEa5R7rPi95HMDLjmjFZFGqo3AuTpIWVygcwBaStSg_oygtRuecArgx5eXmMoDtjtaFP9CzYsl-Aews3yKxaO9lbZo5DkF3n6P7df2IDI1BFKpJAI8WLLRap6RlxVkArzqeWn372k08_u9Kd-AWHpHi_cnw3TbccTgXB8N5Ar12OjdP0Zhqq2f-mPwBrcEZlw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondria-targeted+plastoquinone+derivatives+as+tools+to+interrupt+execution+of+the+aging+program.+3.+Inhibitory+effect+of+SkQ1+on+tumor+development+from+p53-deficient+cells&rft.jtitle=Biochemistry+%28Moscow%29&rft.au=Agapova%2C+L.+S.&rft.au=Chernyak%2C+B.+V.&rft.au=Domnina%2C+L.+V.&rft.au=Dugina%2C+V.+B.&rft.date=2008-12-01&rft.issn=0006-2979&rft.eissn=1608-3040&rft.volume=73&rft.issue=12&rft.spage=1300&rft.epage=1316&rft_id=info:doi/10.1134%2FS0006297908120031&rft.externalDBID=n%2Fa&rft.externalDocID=10_1134_S0006297908120031 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2979&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2979&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2979&client=summon |